Korsana Biosciences (KRSA) Liabilities and Shareholders Equity (2018 - 2025)
Korsana Biosciences (KRSA) posted Liabilities and Shareholders Equity of $9.99 million for Q4 2025, up 4.3% from $9.58 million a year earlier but down 4.1% from the prior quarter.
Powered by 
Analysis
Korsana Biosciences (KRSA) Liabilities and Shareholders Equity (2018 - 2025) Analysis & Trends
Since Q4 2018, Korsana Biosciences has reported Liabilities and Shareholders Equity for 29 quarters.
- Annual Liabilities and Shareholders Equity shows a five-year compound annual growth rate of -38.7% (FY2020 to FY2025).
- In prior years, Korsana Biosciences' Liabilities and Shareholders Equity was $9.58 million in FY2024 (-28.4%), $13.37 million in FY2023 (-26.0%), $18.08 million in FY2022 (-69.5%) and $59.33 million in FY2021 (-48.6%).
- Quarterly Liabilities and Shareholders Equity has run from a low of $8.9 million in Q3 2024 to a high of $99.97 million in Q1 2021 over five years.
- On a year-over-year basis, Liabilities and Shareholders Equity increased in two of the last eight quarters, with an average decline of 8.7%.
- The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was Q3 2025, with growth of 17.0%; the weakest was Q1 2023, with a decline of 75.4%.
- According to Business Quant data, Liabilities and Shareholders Equity for the three prior quarters was $10.42 million (Q3 2025), $9.37 million (Q2 2025) and $9.85 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Korsana Biosciences | 16.89 Mn | 2.44 Mn | - | 9.99 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 9.99 Mn |
| Sep 30, 2025 | 10.42 Mn |
| Jun 30, 2025 | 9.37 Mn |
| Mar 31, 2025 | 9.85 Mn |
| Dec 31, 2024 | 9.58 Mn |
| Sep 30, 2024 | 8.90 Mn |
| Jun 30, 2024 | 10.07 Mn |
| Mar 31, 2024 | 11.36 Mn |
| Dec 31, 2023 | 13.37 Mn |
| Sep 30, 2023 | 15.21 Mn |
| Jun 30, 2023 | 10.10 Mn |
| Mar 31, 2023 | 11.46 Mn |
| Dec 31, 2022 | 18.08 Mn |
| Sep 30, 2022 | 25.05 Mn |
| Jun 30, 2022 | 35.21 Mn |
| Mar 31, 2022 | 46.53 Mn |
| Dec 31, 2021 | 59.33 Mn |
| Sep 30, 2021 | 67.74 Mn |
| Jun 30, 2021 | 75.73 Mn |
| Mar 31, 2021 | 99.97 Mn |
API Access
Korsana Biosciences Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=KRSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "KRSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=KRSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();